Cargando…

Efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns

Current treatment strategies against the development of corrosive esophageal strictures remain unsatisfactory. Thus, the aim of the present study was to investigate the efficacy of keratinocyte growth factor, in the form of palifermin, for the prevention of stricture development following esophageal...

Descripción completa

Detalles Bibliográficos
Autores principales: NUMANOĞLU, KEMAL VARIM, TATLI, DUYGU, BEKTAŞ, SIBEL, ER, EBUBEKIR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151670/
https://www.ncbi.nlm.nih.gov/pubmed/25187801
http://dx.doi.org/10.3892/etm.2014.1851
_version_ 1782333046055239680
author NUMANOĞLU, KEMAL VARIM
TATLI, DUYGU
BEKTAŞ, SIBEL
ER, EBUBEKIR
author_facet NUMANOĞLU, KEMAL VARIM
TATLI, DUYGU
BEKTAŞ, SIBEL
ER, EBUBEKIR
author_sort NUMANOĞLU, KEMAL VARIM
collection PubMed
description Current treatment strategies against the development of corrosive esophageal strictures remain unsatisfactory. Thus, the aim of the present study was to investigate the efficacy of keratinocyte growth factor, in the form of palifermin, for the prevention of stricture development following esophageal caustic injuries in a rat model. A total of 32 female Wistar albino rats were divided into four groups, which included the control (C), burn (B), steroid (S) and steroid plus palifermin (S/P) groups. An experimental corrosive esophageal burn model was established in the B, S and S/P groups. Weight gain was recorded and histopathological evaluation was performed for each group. Weight gain in the S and B groups was compared with the control group and statistically significant differences were observed. In addition, statistically significant differences in weight gain were observed between the S/P group and the B group. Histopathologically, statistically significant differences were identified with regard to submucosal collagen deposition, muscularis mucosa and tunica muscularis damage when comparing the B group with the C group. In addition, statistically significant differences were observed when comparing the S and S/P groups with the B group. Furthermore, significant submucosal collagen deposition and tunica muscularis damage were observed in the S group when compared with the S/P group. The stenosis indexes in the C and S groups were significantly lower compared with the B group. In addition, the stenosis index in the S/P group was significantly lower compared with the S group. To the best of our knowledge, the present study is the first to investigate the effect of palifermin on corrosive esophageal burns. The addition of palifermin to the corrosive esophageal burn standard treatment regimen was found to reduce the degree of fibrosis and ameliorate histopathological damage in an experimental model of corrosive esophagitis in rats.
format Online
Article
Text
id pubmed-4151670
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-41516702014-09-03 Efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns NUMANOĞLU, KEMAL VARIM TATLI, DUYGU BEKTAŞ, SIBEL ER, EBUBEKIR Exp Ther Med Articles Current treatment strategies against the development of corrosive esophageal strictures remain unsatisfactory. Thus, the aim of the present study was to investigate the efficacy of keratinocyte growth factor, in the form of palifermin, for the prevention of stricture development following esophageal caustic injuries in a rat model. A total of 32 female Wistar albino rats were divided into four groups, which included the control (C), burn (B), steroid (S) and steroid plus palifermin (S/P) groups. An experimental corrosive esophageal burn model was established in the B, S and S/P groups. Weight gain was recorded and histopathological evaluation was performed for each group. Weight gain in the S and B groups was compared with the control group and statistically significant differences were observed. In addition, statistically significant differences in weight gain were observed between the S/P group and the B group. Histopathologically, statistically significant differences were identified with regard to submucosal collagen deposition, muscularis mucosa and tunica muscularis damage when comparing the B group with the C group. In addition, statistically significant differences were observed when comparing the S and S/P groups with the B group. Furthermore, significant submucosal collagen deposition and tunica muscularis damage were observed in the S group when compared with the S/P group. The stenosis indexes in the C and S groups were significantly lower compared with the B group. In addition, the stenosis index in the S/P group was significantly lower compared with the S group. To the best of our knowledge, the present study is the first to investigate the effect of palifermin on corrosive esophageal burns. The addition of palifermin to the corrosive esophageal burn standard treatment regimen was found to reduce the degree of fibrosis and ameliorate histopathological damage in an experimental model of corrosive esophagitis in rats. D.A. Spandidos 2014-10 2014-07-17 /pmc/articles/PMC4151670/ /pubmed/25187801 http://dx.doi.org/10.3892/etm.2014.1851 Text en Copyright © 2014, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
NUMANOĞLU, KEMAL VARIM
TATLI, DUYGU
BEKTAŞ, SIBEL
ER, EBUBEKIR
Efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns
title Efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns
title_full Efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns
title_fullStr Efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns
title_full_unstemmed Efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns
title_short Efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns
title_sort efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151670/
https://www.ncbi.nlm.nih.gov/pubmed/25187801
http://dx.doi.org/10.3892/etm.2014.1851
work_keys_str_mv AT numanoglukemalvarim efficacyofkeratinocytegrowthfactorpaliferminforthetreatmentofcausticesophagealburns
AT tatliduygu efficacyofkeratinocytegrowthfactorpaliferminforthetreatmentofcausticesophagealburns
AT bektassibel efficacyofkeratinocytegrowthfactorpaliferminforthetreatmentofcausticesophagealburns
AT erebubekir efficacyofkeratinocytegrowthfactorpaliferminforthetreatmentofcausticesophagealburns